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Resumé:	  
Le système nerveux autonome cardiaque est devenu une cible dans les thérapies 
ablatives de la fibrillation auriculaire. Nous avons étudié les voies de communication 
et la fonction des plexus ganglionnaires (PG) de l'oreillette gauche (PGOG) afin de 
clarifier la validité physiopathologique des méthodes de détection et des thérapies 
impliquant ces groupes de neuronnes. Méthodes: Vingt-deux chiens ont subi une 
double thoracotomie et ont été instrumentés avec des plaques auriculaires 
épidcardiques de multiélectrodes. Une stimulation électrique (2 mA, 15 Hz) des 
PGOG a été réalisée à l'état basal et successivement après: 1) une décentralisation 
vagale, 2) l'ablation par radiofréquence des plexus péri-aortiques et de la veine cave 
supérieure (Ao/VCS) et 3) l'ablation du PG de l'oreillette droite (PGOD). Ces 
procédures de dénervation ont été réalisées suivant  une séquence antérograde (n = 
17) ou rétrograde (n = 5). Résultats: Chez 17 des 22 animaux, la stimulation des 
PGOG a induit une bradycardie sinusale (149 ± 34 bpm vs 136 ± 28 bpm, p < 0.002) 
et des changements de repolarization (ΔREPOL) auriculaires isointégrales. Dans le 
groupe des ablations antérogrades, les réponses aux stimulations vagales ont été 
supprimées suite à la décentralisation vagale chez un seul animal, par l'ablation des 
plexus Ao/VCS dans 4 cas et par l'ablation du PGOG dans 5 autres animaux. Des 
changements ont persisté tout au long chez 2 chiens. La valeur de surface des 
ΔREPOL a diminué avec les dénervations séquentielles, passant de 365 ± 252 mm2 
en basale à 53 ± 106 mm2 après l'ablation du PGOD (p < 0.03). Dans le groupe de 
dénervation rétrograde, les changements de repolarisation et chronotropiques ont été 
supprimés suite à l'ablation du PGOD chez deux chiens et suite à l'ablation Ao/VCS 
chez trois. La valeur de surface du ΔREPOL a aussi diminué après l'ablation du 
PGOD (269±144mm2 vs 124±158mm2, p<0.05). Conclusion: Les PGOD sont 
identifiables en préablation par la réponse bradycardique à la stimulation directe 
dans la plupart des cas. Le PGOD semble former la principale, mais non la seule, 
voie de communication avec le nœud sinusal. Ces résultats pourraient avoir des 
implications dans le traitement de la FA par méthodes ablatives. 
Mots clés: Fibrillation auriculaire, système nerveux intrinsèque cardiaque, plexus 
ganglionnaire de l'oreillette gauche, neurocardiologie, système nerveux autonome. 
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Abstract	  	  
The cardiac autonomic nervous system has recently become the target of 
ablative therapy in the treatment of atrial fibrillation. We investigated the pathways 
and function of the left atrial ganglionated plexus (LAGP) to clarify the 
pathophysiologic validity of therapies involving this cluster of neurons. Methods: 
Twenty-two bilaterally thoracotomized canines were instrumented with atrial 
epicardial plaques. LAGP stimulation was performed in the basal state and 
successively following 1) vagal decentralization, 2) radiofrequency ablation of the 
peri-aortic/superior vena caval (Ao/SVC) plexi, and 3) of the right atrial 
ganglionated plexus (RAGP). Denervation was carried out in either the 
aforementioned order (n=17, antegrade) or reversed (n=5, retrograde). Results: In 
17 of 22 animals, LAGP stimulation induced a sinus bradycardia (149±34bpm	  to	  136±28bpm, p<0.002) and atrial isointegral repolarization changes (REPOL∆). In 
the antegrade group, response was suppressed by vagal decentralization (n=1), 
Ao/SVC plexi ablation (n=4), and RAGP ablation (n=5). Changes persisted 
throughout in 2 canines. Surface area of REPOL∆ diminished with successive 
denervation, from 365±252 at baseline to 53±106mm2 following RAGP ablation 
(p<0.03). With retrograde denervation, chronotropic and repolarisation changes were 
suppressed following RAGP ablation in two canines, and following Ao/SVC 
ablation in three. Surface area of REPOL∆ diminished following RAGP ablation as 
well (269±144mm2 vs 124±158mm2, p<0.05). Conclusion: The LAGP can be 
identified intraoperatively by the bradycardic response to direct stimulation in most 
cases. The RAGP appears to be the primary, but not the only, gateway to the sinus 
node. These results could have important clinical implications relating to ablative 
treatment of atrial fibrillation. 
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Chapter 1.   Atrial fibrillation and the Autonomic 
Nervous System 
1.1 What is atrial fibrillation? 
Atrial fibrillation (AF) is characterized by disorganized atrial electrical 
activity leading to rapid, irregular activation of the atrium. This activation can be in 
the order of 400-600 pulses per minute in a given segment of atrial muscle and 
results in asynchronous and inefficient atrial contraction.1 It can be recognized on 
the surface electrocardiogram by the absence of the P wave (atrial wave), which is 
replaced by low amplitude irregular oscillatory waves, termed fibrillatory waves.2 
AF is the most prevalent cardiac arrhythmia in humans, being responsible for 33% 
of hospitalizations for cardiac rhythm disturbances. The prevalence has best been 
studied in the American population and is estimated to be 0.4-1% of the general 
population, with a larger proportion of the elderly being affected.3 This corresponds 
to 2.2 million Americans and is likely to increase to 5.6 million by the year 2050 as 
a result of the aging population and increasing prevalence of cardiac disease.4 
1.1.1 Classification 
There have been several classification systems proposed for AF. One of the 
most commonly used in clinical practice is based on AF duration. If AF terminates 
spontaneously it is termed paroxysmal, while AF lasting 7 days or more is termed 
persistent. If it lasts more than 1 year it is designated permanent AF.5 Dr Jim Cox, a 
pioneer in the surgical treatment of AF has proposed a simplified classification, with 
Atrial fibrillation being either paroxysmal or chronic.6 He advocates this 
nomenclature because it will best separate patients according to the ideal therapeutic 
intervention. Another classification method is based on the underlying disease, for 
example, AF can be related to mitral stenosis, mitral regurgitation, or 
cardiomyopathy.7 AF that occurs in the absence of identifiable concomitant cardiac 
disease is termed “lone AF”, accounting for 10-30% of AF cases.7, 8 The autonomic 
nervous system has been implicated in the induction of AF due to imbalance, with 
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either parasympathetic or sympathetic hyperactivity.9 It is generally recognized that 
AF occurring in the postoperative period following cardiac surgery falls into a 
separate category. Postoperative AF occurs following 11% to 40% of coronary 
artery bypass graft (CABG) surgeries and as many as 50% of cardiac valvular 
surgeries.10 The onset of this subtype of AF is typically on the second or third 
postoperative day.11, 12 It is thought to be related to inflammation resulting from 
surgical manipulation and extracorporeal circulation fluid shifts and endogenous and 
exogenous catecholamine release.13-15 Although it is often a self limiting problem 
with 90% of patients returning to sinus rhythm at 6-8 weeks, it is associated a with 
significantly longer hospital stay as well as higher in-hospital and long term 
mortality.16-18 
1.2 Clinical Implications 
1.2.1 Morbidity and mortality 
The clinical consequences of AF can be varied, ranging from slight 
discomfort due to palpitations to more severe complications such as stroke or 
death.19, 20 This morbidity is related to the three different problems created by AF. 
Firstly, the chaotic atrial activation leads to an irregular ventricular response 
resulting in the sensation of palpitations, which can lead to patient discomfort.21 
These symptoms occur more frequently in patients with paroxysmal AF, that is, 
those having a rhythm that fluctuates between sinus rhythm and AF.22 Secondly, 
stasis of blood in the left atrium can lead to the formation of clot within the heart and 
predispose a patient to thromboembolic events, resulting in damage to the kidneys, 
intestine, extremities or brain.23, 24 For example, AF has been associated with a three 
to five time increase in the risk of stroke and as many as 30% of acute strokes occur 
in patients with AF.20, 25 This can have severe consequences leading to significant 
impairment of quality of life or even death.26 Finally, the loss of synchronous 
atrioventricular contraction can have important physiologic effects. Ventricular 
filling can be diminished thereby reducing exercise tolerance or leading to 
decompensated cardiac insufficiency by aggravating pre-existing compensated heart 
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failure.27 AF with an ill-controlled ventricular response can also result in 
“tachycardia-induced cardiomyopathy” brought on by prolonged rapid ventricular 
rates, a condition that is for the most part reversible.28 Overall, AF is associated with 
a 1.5 and 1.9 fold increase risk of death in men and women, respectively.29 
1.2.2 Cost 
Although it is difficult to determine the true financial impact of AF on the 
health care system, it is clear that it is a costly public health issue. A study from the 
United Kingdom suggested the direct cost of AF on the health care system in the 
year 2000 to be over 700 million dollars, accounting for almost 1% of total National 
Health Service expenditures. This was a 50% increase from the cost five years 
earlier.30 Another European study estimated that AF costs the healthcare system 
between 2000$ and 3000$ per patient per year. With the high prevalence and 
increasing incidence of this disease, this amounts to an enormous burden on the 
healthcare system.31 
1.3 Risk Factors 
Although there are many factors associated with the development of AF, 
advanced age is the most significant independent risk factor. The exact cause for the 
increased prevalence in the elderly is incompletely understood but it is likely a 
combination of several phenomena associated with aging tissues, including atrophy 
of atrial muscle, atrial dilatation, and slowed or abnormal conduction.32 Aside from 
age, other important risk factors include male sex, hypertension, congestive heart 
failure, atrial dilatation, and valvular disease.33 Additional risk factors include 
coronary artery disease, recent myocardial infarction, hypothyroidism, sleep apnea, 
diabetes, obesity, metabolic syndrome and the postoperative state.33-37 Many other 
factors have been identified that predispose a patient to atrial fibrillation following 
open-heart surgery, these include a history of atrial fibrillation, valvular surgery, and 
withdrawal from beta-blockers or ACE inhibitors18, 38  
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1.4  Pathophysiology 
The pathophysiology and mechanisms of AF are complex and still 
incompletely understood. Despite this, beginning with a basic explanation of the 
fundamentals of the arrhythmia will permit a build-up to a comprehensive 
understanding of our knowledge to date. The onset of AF depends on the presence of 
two key elements: a trigger, i.e. an initiating event, and an anatomical substrate 
enabling AF maintenance1. The initiating event may result from a rapidly firing 
ectopic focus, multiple functional re-entrant circuits, or both.1 Atrial histological and 
electrical changes allowing for AF maintenance may be pre-existing or may be 
induced by the presence of continually firing triggers causing atrial remodelling.  
 
  
Figure 1. Relationship between the various forms of AF.  The	  trigger	  will	  initiate	  the	  re-­‐entry	  phenomenon.	  If	  the	  anatomical	  or	  electrophysiological	  substrate	  is	  insufficient	  to	  perpetuate	  re-­‐entry,	  the	  sequence	  will	  terminate	  with	  an	  atrial	  extrasystole	  (APC,	  atrial	  premature	  complex).	  In	  paroxysmal	  AF,	  the	  arrhythmia	  will	  be	  initiated	  by	  a	  trigger,	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however,	  the	  substrate	  is	  insufficient	  to	  maintain	  AF	  and	  a	  spontaneous	  cardioversion	  ensues.	  In	  persistent	  AF	  the	  atrial	  substrate	  is	  sufficient	  to	  maintain	  a	  fibrillatory	  state	  but	  the	  arrhythmia	  can	  still	  be	  terminated	  with	  a	  therapeutic	  intervention.	  Permanent	  AF	  is	  present	  when	  severity	  of	  atrial	  remodelling	  makes	  it	  no	  longer	  possible	  to	  return	  to	  sinus	  rhythm.	  CV=	  Cardioversion39	  
1.4.1 Mechanisms of atrial fibrillation 
In the early twentieth century three competing theories regarding the 
mechanisms of AF were suggested. They postulated that AF is derived from 1) 
rapidly discharging atrial ectopic foci, 2) a single re-entry circuit, or 3) multiple re-
entry circuits.40 These theories have been both disputed and modified over the years 
and have helped shape our current understanding of this complex arrhythmia. 
Whatever the exact mechanism, it appears that AF begins with abnormal impulses 
arising from atrial tissue. While normal automaticity results from the spontaneously 
depolarizing sinus node cell reaching threshold potential, ectopy can result either 
from other cells depolarizing at an abnormally rapid rate, or from 
afterdepolarizations reaching threshold and causing premature action potentials. 
Conversely, re-entry can occur as a result of a premature impulse propagating 
between two zones of tissue with different refractory periods.1 In order for AF to be 
initiated, a premature activation must occur on the border between these two zones 
creating a unidirectional block when the impulse contacts one of the zones during its 
refractory period. Once the refractory period has terminated, the atrial tissue can 
then be re-excited and allow for propagation of the pathologic impulse. Once 
initiated, this circuit can continue indefinitely. With increased atrial tissue 
heterogeneity, the likelihood of unidirectional blocks occurring augments and the 
risk of chaotic activation leading to AF is amplified.41-43  
These phenomena are the result of alterations in atrial ionic currents. 
Changes in the balance between the various potassium, sodium and calcium currents 
lead to varied action potential duration and a proarrhythmic state. As an example, in 
response to calcium overload, atrial cells will decrease the concentration of certain 
membrane bound calcium channels in order to preserve cell viability.44 However, 
those same calcium channels contribute to the action potential plateau and their 
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decreased membrane concentration will decrease the action potential duration, which 
in turn reduces the refractory period and promotes the maintenance of AF by 
multiple circuit re-entry.45, 46 
There are two competing models regarding the mechanism of re-entry. 
Allessie et al proposed the “leading circle hypothesis” which relies on the theory that 
there is a small circuit established with the smallest diameter possible that will 
maintain continuous activity.41 This minimum circuit size is defined as the product 
of the refractory period and the conduction velocity. The core of the circle is 
continuously excited by impulses originating from the outer circle. Pertsov et al 
suggested the “spiral wave theory” in 1993.47 This model depends on a fully 
excitable core with the maintenance of spiral wave re-entry dependant on the 
curvature of the wavefronts at the tip of the spiral. Each of these theories come with 
inherent limitations, highlighting the fact that although we have come a long way in 
understanding this complex arrhythmia, there is still work to be done.  
1.4.2 Electrical remodelling – AF begets AF 
The idea of tachycardia induced electrical remodelling was first suggested by 
two independent animal studies performed in the mid 1990’s. In a dog model of 
chronic rapid atrial pacing, Morillo et al demonstrated a shortening of the atrial 
refractory period and more readily inducible sustained AF.48 Wijffels et al developed 
a chronic goat model of sustained AF by attaching implanted electrodes to a 
fibrillation pacemaker that automatically delivered bursts of stimuli whenever sinus 
rhythm occurred.49 By artificially maintaining AF, they showed even more marked 
refractory period shortening as well as increased inducibility and stability of AF. 
These observations led to the concept of “Atrial Fibrillation Begets Atrial 
Fibrillation”, that tachycardia induced remodelling creates a substrate for persistent 
AF.49 Although the results of these experiments opened a new avenue for 
researching and understanding AF, they failed to fully explain the phenomenon 
being witnessed. The changes of atrial refractory period demonstrated by Wijffels et 
al were near maximal after 24 hours, whereas the duration of AF continued to 
increase for 2 weeks.49 In the years since the publication of these seminal papers 
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additional factors explaining tachycardia induced remodelling, including conduction 
velocity, wavelength and regional heterogeneity, have been proposed.46 The basis of 
these changes have since been linked to ionic mechanisms, some of which are 
described above, most important of which is a reduction in L-type calcium 
channels.50, 51 
1.4.3 Histological changes 
The alterations in atrial tissue most frequently seen as consequences of AF 
are atrial fibrosis and loss of atrial muscle mass. It is important to mention that 
before anatomical changes occur, electrical remodelling is brought on by the initial 
AF stimulus. If AF is allowed to continue, anatomical remodelling will occur 
subsequently. Atrial fibrosis favours the development of re-entry circuits by creating 
physical barriers within the atria impeding the propagation of electrical activity. This 
causes a heterogeneous slowing of atrial conduction, as is the case in heart failure.52 
The renin-angiotensin-aldosterone system (RAAS) plays an important role in the 
development of atrial fibrosis. The RAAS is activated in response to atrial dilatation, 
with an increased expression of angiotensin converting enzyme within the atrial 
tissue. Angiotensin II and aldosterone facilitate the proliferation of fibroblasts and 
the deposition of proteins within the extracellular matrix, thus altering atrial 
structure.53 Angiotensin receptor blockers and angiotensin converting enzyme 
inhibitors, medications frequently used for the control of blood pressure and in the 
treatment of heart failure, have been shown to delay or reduce the development of 
fibrosis and AF.54, 55 
1.4.4 Autonomic influences 
The development of AF can be secondary to changes in cardiac nervous tone 
as well. Coumel was one of the first to suggest that AF could result from increase in 
signalling of either of the components of the autonomic nervous system (ANS), i.e. 
sympathetic or parasympathetic.56 He noted that when patients are asleep they can 
have AF episodes preceded by a sinus bradycardia, suggesting a vagal origin.57 
Conversely, it has been shown that AF can be associated with increased sympathetic 
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tone in the presence of intense emotional or physical stressors.58 Coumel suggests 
that sympathetic AF occurs in patients with concomitant cardiac disease, while vagal 
AF in seen primarily in the absence of structural heart disease and generally yields 
paroxysmal AF.58 The role of the ANS in AF is evidenced by the RR interval 
variation, corresponding to the distance between the two R waves (positive 
deflection of the QRS complex of ventricular depolarisation) on the 
electrocardiogram. This parameter has been shown to reliably identify sympathetic 
and parasympathetic influences on the heart, and variations recorded immediately 
prior to the onset of AF have made it possible to link these episodes to autonomic 
nervous system activity.59, 60 The specific and relative contributions of each arm of 
the ANS remains to be determined, but the evidence is increasingly pointing to a 
synergistic effect between the sympathetic and parasympathetic systems.61, 62 
Changes in nervous tone in localized areas of the atrium create various zones with 
heterogeneous refractory periods. The result is zones of functional block favouring 
re-entry and, consequently, AF.58 Hirose et al demonstrated that direct stimulation of 
the vagus nerves increases the heterogeneity of atrial refractory periods, thus 
facilitating induction of AF.63 In a series of canine preparations, Jayachandran et al 
demonstrated that rapid AF, induced by rapid atrial pacing, results in a 
heterogeneous increase in atrial sympathetic innervation, with greatest heterogeneity 
in the right atrium.64 Since the establishment of the role of the ANS in the 
pathophysiology of AF, further research has illuminated the importance of several 
anatomical sites as they relate to AF origin. 
1.4.5 Anatomical origins of AF 
The pulmonary veins 
Various atrial regions have been reputed to play important roles in the 
initiation and maintenance of AF. The base of the pulmonary veins has emerged as a 
preferential site of micro and macro re-entry.65 Haissaguerre was the first to identify 
this area as an important source of AF. While performing electrophysiological 
studies on a series of patients with drug refractory AF, he noted multiple ectopic 
atrial beats originating at the base of the pulmonary veins.66 He demonstrated that 
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the origin of AF was found within a muscular band at the junction of the left atrium 
and the pulmonary veins.67 The relatively chaotic organization of the area, including 
the orientation, sheathing, and ending of the muscular fibres, tends to favour the 
creation of local re-entrant circuits.67-69 The embryologic origins of the pulmonary 
veins partially explain the aforementioned “chaotic” arrangement of these fibres. 
The base of the pulmonary veins represent the junction between the trunk of the 
pulmonary venous system, derived from the embryonic anterior intestine, and the 
left atrium, derived the primitive cardiac tube. The ionic characteristics of myocytes 
in this area also favour re-entry as a result of shorter refractory periods.70, 71  
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Figure 2. Schematic of superficial muscular fibres of the left atrium. A	  main	  circular	  fascicle	  (a,	  a’,	  a”,	  and	  a”’)	  runs	  peripherally	  around	  the	  area	  of	  the	  openings	  of	  the	  pulmonary	  veins,	  while	  an	  interatrial	  fascicle	  (b)	  runs	  between	  the	  right	  (RA)	  and	  the	  left	  (LA)	  atrium.	  Some	  fibres	  (c)	  descend	  from	  the	  left	  atrium	  into	  the	  left	  part	  (a’)	  of	  the	  main	  circular	  fascicle.	  Circular	  fibres	  leaving	  the	  main	  fascicle	  turn	  around	  the	  openings	  of	  the	  pulmonary	  veins,	  forming	  sphincter-­‐like	  structures;	  other	  fibres	  extend	  over	  the	  veins	  as	  myocardial	  sleeves.	  Loops	  of	  fibres	  coming	  from	  the	  atrium	  are	  seen	  over	  the	  right	  superior	  pulmonary	  vein	  (R.S.P.V.)	  and	  returning	  to	  the	  atrium.	  Oblique,	  vertical	  (e),	  and	  transverse	  (f,	  f’)	  fascicles	  of	  fibres	  are	  also	  seen	  on	  the	  posterior	  atrial	  surface.	  L.A.	  =	  left	  atrium;	  R.A.	  =	  right	  atrium;	  S.V.C.	  =	  superior	  vena	  cava;	  I.V.C.	  =	  inferior	  vena	  cava;	  R.S.P.V.	  =	  right	  superior	  pulmonary	  vein;	  L.S.P.V.	  =	  left	  superior	  pulmonary	  vein;	  L.I.P.V.	  =	  left	  inferior	  pulmonary	  vein.	  (Reproduced	  from	  Nathan	  et	  al,	  Circulation	  34(3):412-­‐422,	  1966).	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Other sites of origin 
There are several sites other than the pulmonary veins that have been 
identified as foci of AF initiation. In general, the junction between the atria and all 
major thoracic veins constitute possible sites of re-entry.72 Although the left atrium 
is generally considered to be the more common site of AF initiation, the right atrium 
is also a potential source. Examples of the right atrium’s arrhythmogenic potential 
have been seen following surgical or percutaneous interventions targeting only the 
pulmonary veins. Firstly, the onset of left atrial flutter can seen, possibly a result of 
incomplete ablation lines within the left atrium. Secondly, the elimination of left 
atrial AF mechanisms may allow for the emergence of right atrial sites that were 
otherwise overshadowed by their left atrial counterparts.73 Forleo et al demonstrated 
that complex fractionated atrial electrograms were present in the right atrium and 
coronary sinus during pulmonary vein isolation procedures.74 Even more 
interestingly, the authors were able to link these electrograms to an increased risk of 
AF recurrence. While there has previously been controversy regarding the right 
atrium’s ability to initiate AF in the absence of left atrial sources, there is an 
increasing amount of evidence supporting this theory. When performing 
electrophysiological studies in 172 patients with AF, Chen et al identified sites of 
focal AF within the right atrium of 8 patients.75 These sites were the crista terminalis 
(the right atrial free wall) and at the ostium of the coronary sinus. Similarly, Tsai et 
al demonstrated loci of ectopic beats at the SVC-right atrial junction that appeared to 
be sites of AF origin.76 In both of these studies the authors were able to eliminate AF 
by radiofrequency ablation of these areas. 
Interatrial conduction pathways comprise another group of atrial tissue with a 
tendency to initiate AF. Although any atrial tissue has the ability to propagate an 
electrical signal, conduction tends to occur via certain preferential tracts. The 
importance of Bachmann’s bundle, also known as the interatrial band, as it relates to 
interatrial conduction was first described in 1916 by George Bachmann.77 It is 
located at the upper extremity of the interatrial septum and the results of several 
studies have suggested its role in AF pathophysiology.78-80 Other atrial structures 
studied in this context include the coronary sinus and fossa ovalis.81 Finally, another 
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area of the atria that has been implicated in several studies as a site of AF origin is 
the ligament of Marshall. The ligament of Marshall is an atrial fold located adjacent 
to the coronary sinus in the inferior left atrium that is a remnant of the left horn of 
the sinus venosus in the foetus. It contains nerve fibres, muscle bundles, and the 
oblique auricular vein, the vein of Marshall.82 The Marshall bundle is considered the 
most important interatrial conduction pathway in the inferior portion of the atria and 
is likely the site of AF origin in certain patients.83, 84 Concordant with this assertion 
are the findings by Haissaguerre et al that the epicardial and endocardial regions 
bordering the coronary sinus are important in the maintenance of AF.85, 86 
Considering the above, it is clear that the sites of origin of AF are closely related to 
the anatomy and development of cardiac conduction tissue; consequently, a brief 
discussion of the embryologic development of cardiac conduction tissue will follow. 
1.4.6 Embryologic development of the cardiac conduction 
system 
Although the development of the cardiac conduction system remains 
controversial, one of the most accepted theories explaining the sequence of 
depolarisation of myocardial tissue is that of the integration of the neural crest 
during fetal development.87, 88 Neural crest cells are said to participate in the 
formation of the four cardiac chambers and in the development of the cardiac 
conduction system.88, 89 The ectomesenchymal neural crest cells migrate to the heart 
by routes along arterial and venous structures. The cells on the arterial side develop 
into the semilunar valves, while those on the venous side become integrated into the 
myocardium to form the atrio-ventricular node (AVN), the bundle of His, and the 
ventricular conduction branches.90, 91 In addition, other authors have demonstrated a 
high concentration of cells surrounding the pulmonary veins.92 In addition to its role 
in the morphogenesis of the cardiac chambers and the conduction system, the neural 
crest is implicated in the development of the intrinsic cardiac innervation.93 This link 
between the nervous system and the heart is of utmost importance both in normal 
and pathologic cardiac function. There are a multitude of nervous fibres and 
ganglionated plexi on the surface of the heart that are important for the beat-to-beat 
 13	  
functioning of the heart.94, 95 These autonomic nervous ganglia are preferentially 
distributed within epicardial adipose tissue at the base of the heart between the atria 
and ventricles, as well as around the great vessels. They have the ability to modify 
cardiac chronotropy, dromotropy, inotropy, lusitropy and bathmotropy.96 The details 
of the cardiac autonomic innervation are in constant evolution but a review of our 
understanding to date is necessary in order to appreciate the findings of this work.   
1.5 The nervous system and the heart 
1.5.1 Neurocardiology 
The ANS is responsible for maintaining homeostasis in the body. Classically, 
cardiac nervous control is said to result from a delicate balance between the two 
branches of the ANS, sympathetic and parasympathetic. Sympathetic influence is 
said to stimulate the heart, resulting in increased heart rate and force of contraction. 
While the parasympathetic, or vagal, influence has the opposite effect.97  
The “classic” view of cardiac nervous control entailed the assumption of the heart’s 
passive response to postganglionic sympathetic and parasympathetic signals, 
originating in the central nervous system (CNS).98 However, although this concept 
of neuroanatomic organization held for over a century, it is now known that this not 
the entire picture. There exists a complex hierarchy of nervous structures that 
interact to influence cardiovascular function. The nervous structures that are 
implicated in this process are located at different levels of the body, notably in the 
brain (CNS), thoracic cage (extrinsic cardiac nervous system), and on the heart 
(intrinsic cardiac nervous system). This hierarchy is composed of many levels of 
feedback control loops that includes parasympathetic and sympathetic efferent and 
afferent neurons, intraganglionic neurons, and interganglionic neurons (Figure 3).99 
The notion of the heart’s capacity for local integration and processing of neuronal 
signals was first put forth in the early 1970’s by Armour and Ardell.100, 101 102-104 It 
allows for the local integration and control of the many cardiac parameters that can 
be affected by the autonomic nervous system.104-106  
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Figure 3 Proposed model for the cardiac neuronal hierarchy, emphasizing the 
intrathoracic components.95 
1.5.2 The extrinsic cardiac nervous system 
The thoracic cage is rich with both efferent (toward the heart) and afferent 
(toward the brain) nervous structures that are active in coordinating the nervous 
influences of the heart. This is the substrate of the extrinsic cardiac nervous system, 
with the efferent structures acting on the heart consisting of those descending from 
the CNS as well as the intrathoracic extracardiac ganglia. The coordination and local 
processing of these neuronal signals is mediated by local circuit neurons located 
within the intrathoracic ganglia.105 
Transmission of information occurs between the CNS and the end-organ via 
a connection of two neurons in series, termed preganglionic and postganglionic. The 
preganglionic neurons develop from the neural tube and postganglionic from the 
neural crest. Preganglionic sympathetic neurons synapse in the paravertebral 
ganglionic chains. The principal sympathetic efferent ganglia innervating the heart 
are the stellate and median cervical ganglia. Parasympathetic innervation of the heart 
stems primarily from the nucleus ambiguus of the brain stem and is relayed to the 
heart through the vagus nerve, also called the vagosympathetic complex, with the 
 15	  
pre-post ganglionic synapse occurring at the level of the heart itself (Figure 4).107-109 
The axons exiting the nucleus ambiguus are composed of large myelinated fibres 
allowing for rapid transmission of neural signals with short latency between 
activation and the end organ effect of vagal bradycardia.110 The principal 
parasympathetic afferent pathway, i.e. neuronal pathways leading away from the 
heart and toward the CNS, is the nodose ganglion, also known as the inferior 
ganglion of the vagus nerve. It has a cylindrical form and runs along the anterior 
aspect of the internal jugular vein.  Cardiac sympathetic afferents reach the CNS via 
the dorsal root ganglia running along the spinal cord.111 
 
Figure 4 Schematic representation of the extrinsic cardiac nervous system at 
the level of the thoracic nerves.109. 
The local circuit neurons mentioned previously are a sub-population of 
neurons contained within the autonomic ganglia of both the intrathoracic 
extracardiac and intrinsic cardiac systems. They have projections to adjacent 
neurons within their own ganglion, or in other regional ganglia, allowing for a 
“functional interconnectivity” within the intrathoracic nervous system.104, 112 The 
result is a capacity to influence cardiac performance in a manner that would not be 
possible with simple neuronal connections in series. 
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1.5.3 The intrinsic cardiac nervous system 
The intrinsic cardiac nervous system (ICNS) is a complex network of 
neuronal fibres where sympathetic and parasympathetic nerves do more than simply 
deposit their signal. It is an extra level of neuronal control located directly on the 
heart’s surface, otherwise known as the “little brain on the heart.”95, 96, 105 Neurons 
are located in the autonomic ganglionated plexi, which are clustered in discrete areas 
of the heart, primarily in the fat tissue on the epicardial surface of the heart. Four 
types of neurons can be found within these ganglia: efferent sympathetic and 
parasympathetic neurons, interneurons contained entirely within individual ganglion, 
local circuit neurons linking intracardiac ganglia, and sensory neurons mediating 
intracardiac reflexes.113 The anatomical details of the atrial ganglionated plexi will 
be discussed below. 
1.5.4 Anatomy of the intrinsic cardiac nervous system 
The most complete account of the anatomy of ICNS was first described for 
the canine heart by Yuan et al in 1994.114(Figure 5) Cardinal et al recently published 
a reproduction of Yuan’s classification system.115(Figure 6) Armour et al. used this 
work as a basis for their description of the human ICNS in 1997.96 They analysed the 
hearts of 18 subjects and elaborated on the gross and microscopic anatomical details. 
They were able to consistently identify ganglionated plexi in five atrial and five 
ventricular locations (Figure 7)(Figure 8). Each ganglion contained anywhere from 
one to over 200 neurons. It is important to note that the precise location and size of 
each ganglion varied somewhat between specimens. They also noted connections 
between ganglia within each region forming “regional neural networks.” The atrial 
ganglionated plexi as detailed by Yuan et al114 are described below: 
1) The right atrial ganglionated plexus (RAGP) is located in the adipose 
tissue just cephalad to the right atrial-IVC junction and just ventral to the 
interatrial groove. It has been shown that autonomic nervous signals 
preferentially, although not exclusively, pass through this plexus en route to 
the sinus node.116 
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2) The left atrial ventral ganglionated plexus is located on the ventral surface 
of the left atrium, it is comprised of three components: cranial, intermediate, 
and caudal. These were originally described in detail by Armour et al in 
1990.106 
3) The dorsal atrial ganglionated plexus is situated on the dorsal surface of 
the heart between the two atria. 
4) The inferior vena cava-inferior left atrium (IVC-ILA) ganglionated 
plexus is located on the inferior dorsal aspect of both atria, adjacent to the 
entrance of the IVC into the right atrium. This plexus has been linked to the 
autonomic control of the AVN.117  
 
 
Figure 5. Distribution of ganglionated plexi on the canine heart, superior view.  GP	  =	  ganglionated	  plexus,	  PA	  =	  pulmonary	  artery,	  IVC	  =	  inferior	  vena	  cava,	  	  	  	  SVC	  =	  superior	  vena	  cava.	  114	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Figure 6. Anatomical locations of intrinsic cardiac ganglionated plexi in the 
canine heart. A:	  ventral,	  B:	  left	  lateral,	  C:	  dorsal	  views	  of	  the	  heart.	  RAGP	  =	  right	  atrial	  ganglionated	  plexus	  (GP),	  RVGP	  =	  right	  ventricular	  GP,	  CMVGP	  =	  cranial	  medial	  ventricular	  GP,	  VSVGP=	  ventral	  septal	  ventricular	  GP,	  LAGP	  =	  left	  atrial	  GP,	  DAGP	  =	  dorsal	  atrial	  GP,	  IVC-­‐ILA	  =	  inferior	  vena	  cava-­‐inferior	  left	  atrial	  GP.	  VLCN=ventrolateral	  cardiac	  nerve,	  LPA=left	  pulmonary	  artery,	  Ao=aorta,	  IVC,	  SVC=inferior,	  superior	  vena	  cava.	  115	  	  
 
Figure 7. Distribution of ganglionated plexi on the human heart, posterior 
view.96 
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Figure 8. Distribution of the ganglionated plexi on the human heart, superior 
view.96 	  
These ganglionated plexi were initially thought to be comprised of purely 
parasympathetic postganglionic efferents 117-119, without intrinsic neuronal activity 
and without accompanying sympathetic neurons. Both of these assumptions have 
since been refuted by demonstrating spontaneous activity of sympathetic and 
parasympathetic neurons within each plexus.61  
1.6 Management of Atrial Fibrillation 
The treatment of AF generally involves any or all of 3 objectives – the 
control of ventricular rate, prevention of thromboembolism, and restoration of sinus 
rhythm. The goals of treatment are tailored to each patient based on symptoms and 
comorbid conditions. Subclassification according to therapeutic modality can aid in 
the explanation of AF treatment options.  
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1.6.1 Pharmacologic treatment 
Pharmacologic therapy is generally accepted as the first line of treatment in 
AF5. A variety of medications exist that are used to convert AF to sinus rhythm, 
control ventricular response, or both.26, 120, 121 Accompanying their many benefits, 
these drugs can have significant side effects, including paradoxical proarrhythmic 
effects causing malignant arrhythmias or atrioventricular blockade as well as 
hypotension or exercise intolerance.122, 123 Additionally, depending on the time to 
successful conversion to sinus rhythm, the risk of thromboembolism persists while 
on these medications. Anticoagulation therapy, along with its own substantial 
complication risks, must be maintained.5, 124-126 
1.6.2 Invasive treatment 
The suboptimal pharmacologic treatment options listed above have led to 
much effort focused on developing invasive techniques to control AF over the past 
two decades.127-130 The objectives of these procedures are both to isolate arrhythmic 
foci and eliminate macro re-entry circuits. The maze procedure, described by Dr Jim 
Cox, is now considered the most effective treatment of AF.129 The original 
procedure involved fragmentation of atrial tissue by the “cut and sew” technique. 
This entailed cutting apart the atrium at specific sites and suturing it back together in 
order to limit electrical continuity between certain areas. The resultant scar tissue 
barriers limit, in theory, macro re-entry circuits within the atria.  
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Figure 9. Ablation lines used in the invasive treatment of atrial fibrillation. A	  –	  Left	  sided	  Maze	  procedure.	  B	  –	  Pulmonary	  vein	  isolation.131	  
 
More recently, the less invasive and faster procedures using radiofrequency, 
cryotherapy, and microwave technology, attempt to reproduce the full thickness 
tissue scarring of the original Maze procedure.(Figure 9)132-135 In addition, 
percutaneous techniques have attempted to reproduce the results seen with surgery 
either by mapping the atria and directly ablating complexes that may be precursors 
to AF, or by targeting and isolating the trial tissue giving rise to AF.136  
1.6.3 Invasive treatment of AF – Are we there yet? 
Although the number of AF procedures has been rising consistently, there are 
still questions to be answered about their effectiveness. Many reports boast excellent 
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success rates, however the follow-up in some has been called into question. For 
example, periodic electrocardiograms and telephone interviews regarding symptoms 
may not present an accurate picture of AF recurrence. This weakness is highlighted 
by a study from Hindricks et al that demonstrated patients who were very 
symptomatic from their AF before a percutaneous intervention continued to have 
asymptomatic AF episodes following the procedure.137 These episodes were found 
only with continuous electrocardiographic monitoring for 7 days using a portable 
monitoring device. 
Regardless of how one might feel about the effectiveness of any given 
treatment, be it pharmacologic, percutaneous, or surgical, it is clear that the ideal 
treatment of atrial fibrillation is yet to be proven. The ideal treatment would be 
minimally invasive, very effective, and eliminate the negative consequences of AF, 
most notably symptoms and the need for anticoagulation. Pharmacologic treatment 
is incapable of returning many patients to sinus rhythm and when it does it is often at 
a price of significant complications, including malignant arrhythmias, severe side 
effects, and bleeding.138 Percutaneous and surgical treatment have improved 
dramatically with few complications, however success rates are variable and 
reporting of results are inconsistent, as mentioned above. As a result of the 
abovementioned shortcomings, research in this area has become very active in recent 
years. One of the most active areas of study is the intrinsic cardiac nervous system 
and it’s associated autonomic ganglia. 
1.6.4 The ICNS and control of cardiac functions 
As discussed earlier, the ICNS is both the intermediary between the ANS and the 
heart, as well as an independent entity that contributes to beat-to-beat variations of 
cardiac activity.104 Intrathoracic nervous elements respond to intrinsic stimuli as well 
as extrinsic electrical stimulation, thus raising the possibility of influencing the 
electrophysiological and dynamic properties of the heart.115 Furthermore, Chiou et al 
demonstrated that selective denervation was possible when radiofrequency ablation 
was applied to epicardial ganglionated plexi. They were able to modify the atrial 
response to vagal stimulation by ablating three areas of cardiac ganglionated plexi 
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without affecting the ventricular response to vagal stimulation.139. Other studies 
using dog models have clearly demonstrated that electrical or chemical stimulation 
of various nervous elements can modify cardiac activity.95, 102, 105, 106, 115, 140, 141 
Furthermore, it has been shown that there is considerable redundancy in the cardiac 
innervation, revealing the complexity of the cardiac nervous system.142 The idea of 
modifying cardiac arrhythmias by stimulation and ablation of atrial tissues has been 
exploited in percutaneous and surgical AF interventions.143-146 In summary, the 
ICNS is a potential therapeutic target for modulation of cardiac activity.  
1.6.5 The ICNS as it relates to AF  
As discussed earlier, the pathophysiology of AF involves structural, 
electrical, and neurophysiologic elements. The majority of pharmacologic and 
invasive therapies for AF target the former two elements. The importance of 
neurophysiology, particularly the ICNS, in AF pathogenesis and control is becoming 
more and more evident. In an animal model, Scherlag et al were able to induce AF 
by simulating ectopic firing from the pulmonary veins only if the adjacent 
ganglionated plexi were stimulated simultaneously.147 Huang et al induced 
ventricular arrhythmias with stimulation of intrinsic cardiac neurons in a dog 
model.148 Several other experimental models have implicated ganglionated plexi and 
the ICNS in the initiation of both atrial and ventricular arrhythmias.149, 150 These 
findings have encouraged researchers and clinicians to target the ICNS in novel 
therapies to control or eliminate AF. 
1.6.6 Neuromodulation by direct ablation to control atrial 
arrhythmia. 
There have been an overwhelming number of reports in recent years 
describing results following invasive treatment of AF. Many authors have suggested 
that much success is due to the phenomenon of neuromodulation.82, 136 Pappone et al 
reported on 297 patients who had underwent circumferential pulmonary vein 
ablation, with 34% of these patients having a bradycardic response to stimulation. 
This subgroup of patients seemed to have a better response to ablation with 99% 
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freedom from AF at 12 months compared to 85% in the group not presenting a 
bradycardic response to stimulation. 151 Mehall et al reported a minimally invasive 
approach for atrial fibrillation treatment which included localization of epicardic 
ganglionated plexi by electrical stimulation followed by radiofrequency ablation.152 
Like Pappone, the authors presumed that by localising and ablating ganglionated 
plexi they had eliminated additional arrhythmogenic foci. They propose this to be a 
form of vagal or autonomic denervation and suggest that these should become a 
routine addition to ablative treatment of AF. 
Pappone’s observations led to increased interest in exploring AF treatment 
by direct neuromodulation through denervation. Scherlag et al described a canine 
model in which ganglionated plexus stimulation was thought to enable AF induction 
when performed concomitantly with pulmonary vein stimulation.153 Other authors 
have since reported similar experimental results, however, the causal link between 
ganglionated plexi and AF has yet to be established.154 Schauerte showed that direct 
stimulation of atrial ganglionated plexi led to a shortening of the atrial refractory 
period that facilitated AF.155 They also showed that ablation of those plexi reduced 
the inducibility of AF through vagus nerve stimulation. Observations of this nature 
gave researchers the physiologic basis to modulate atrial arrhythmias through focal 
epicardial ablation. Other authors have reported conflicting results. Hirose, among 
others, found that partial denervation of the right atrium actually increased AF 
susceptibility.63, 156, 157 These observations potentially demonstrate not only the 
relationship between the autonomic nervous system and cardiac arrhythmias, but 
also the possibility to influence atrial arrhythmias through neuromodulation. The 
fact remains that, despite much research, the hypothesis of selective autonomic 
denervation to treat AF has not yet been proven. All studies relating AF to the ANS 
have been through indirect evaluation, relying mostly on heart rate variability to 
implicate ganglionated plexi in experimental or clinical result.  
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1.6.7 Direct neuromodulation: Many unanswered questions  
An ill-defined target 
Although there is some clinical evidence supporting the use of cardiac 
denervation in the treatment of AF, the technique has significant hurdles to 
overcome. Work by Tan et al suggests that the idea of selective neuromodulation 
employed during endovascular and surgical procedures is at best optimistic, since 
each ganglionic bundle contains both sympathetic and parasympathetic neurons.61 
This theoretical problem can be reconciled by considering data from Patterson et al 
who demonstrated in experiments with isolated canine pulmonary veins that 
concomitant simulation of parasympathetic and sympathetic neurons may be more 
effective in induction of atrial ectopy. This suggests that it may in fact be favourable 
to target both types of autonomic influence together. In a human study, Cummings et 
al found that resection of the anterior aortic fat pad actually increased the incidence 
of postoperative AF.156 Finally, although it may be clear that autonomic nervous 
elements are in some way implicated in AF, it is still unclear what these elements 
are, where they can be found, at what level of the ANS they must be targeted, 
intrathoracic versus the ICNS for example, and by what method they should be 
approached. 
Durability of denervation? 
The uncertainties of denervation procedures go beyond selecting the target. 
Even if the arrhythmogenic ganglia were clearly identified, there is significant 
evidence suggesting that effects of denervation on cardiac tissue are only 
transient.158, 159 In a canine model, Murphy et al found evidence of nerves crossing 
suture lines one year following cardiac transplantation.160 Evidence of sympathetic 
re-innervation has been described in the clinical transplant literature as well, with 
growth that occurs even up to 15 years following transplantation.161, 162 Even 
Pappone et al, in their seminal paper on pulmonary vein denervation, remarked that 
heart rate changes associated with vagal stimulation returned to baseline levels at 6 
months, a sign of autonomic re-innervation.151 In an experimental model, Oh et al 
demonstrated that autonomic nervous changes induced by epicardial  ganglionated 
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plexus ablation reverted to normal after 6 weeks.158 Therefore, it would seem that 
cardiac re-innervation might limit the durability of direct neuromodulation. 
A third issue that may limit the applicability of direct neuromodulation in AF 
treatment is the paradoxical reaction that occurs following intervention termed 
“nerve sprouting”.156 Okuyama et al showed that radiofrequency ablation in a dog 
model produced a hyperinnervation of cardiac tissue rather than denervation.163 
Chen et al showed that nerve sprouting following myocardial injury results in an 
electrophysiological heterogeneity that can increase the incidence of ventricular 
tachyarrhythmia.164 
In summary, while direct neuromodulation may play a role in the treatment 
of AF, the ideal method has not yet been described. Furthermore, although some 
have reported clinical success using the bradycardic response as a road map for 
ganglionated plexus ablation, the neurophysiologic and anatomical basis for their 
success, or failure in some cases, is certainly not clear. Although advances in 
science, and medicine in particular, are often stumbled upon by chance, it is of 
utmost importance to explore the fundamentals of these advances in order to better 
understand why or how it has occurred and to help guide clinical practice and future 
development.  
1.7 Hypothesis 
As described above, the intrinsic cardiac nervous system is comprised of 
several ganglionated plexi located in areas of adipose tissue dispersed over the 
epicardial surface of the mammalian heart. According to Yuan et al’s classification, 
there exist 4 atrial ganglionated plexi on the canine heart.114 (Figure 6) It has been 
well established that atrial ganglionated plexi assert some control over various 
cardiac functions including, among other things, chronotropy. However, the 
anatomic pathways followed by these ganglionic nerve fibres have not been 
explored or characterized in any detail. Despite this, there are many authors who, 
during ablative interventions for AF perform electrical stimulation of these areas, 
and upon witnessing a bradycardic response, proceed to ablation of the area (See 
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sections 1.6.6 and 1.6.7). Although some publications report positive outcomes, the 
results are far from conclusive, leaving unresolved questions regarding the 
reproducibility of this technique and the overall arrhythmogenicity of the LAGP 
neurons. Understanding these pathways may play an important role in determining 
the ideal interventions, if any, targeting the intrinsic cardiac nervous system in the 
treatment of atrial fibrillation.  
When considering the anatomic locations of each of the 4 atrial ganglionated 
plexi as they relate to the bradycardic response seen with epicardial stimulation, 
some obvious questions arise. The right atrial ganglionated plexus (RAGP) is in 
close proximity to the sinus node, making it easy to understand the short distance 
nervous structures must travel in order to arrive at the sinus node and effect changes 
in cardiac chronotropy. The left atrial ganglionated plexus (LAGP), however, is 
located lateral to the left pulmonary veins and anatomically distant from the sinus 
node. The physioanatomic pathways of the bradycardic response seen with 
stimulation of the LAGP are appreciably more difficult to comprehend.  
There exist three possible neuroanatomic pathways that could explain the 
mechanism of the sinus bradycardia witnessed with stimulation of the LAGP. 1) A 
central reflex arc via the vagus nerve that travels from the LAGP, to the central 
nervous system and then back down to the right sided heart via the opposite vagus 
nerve. The bradycardic effect of the vagus nerve is beyond question and the neural 
and arrhythmogenic consequences of vagal stimulation have also been well 
established.141 2) A pathway through the pericardiac plexi, namely the periaortic or 
superior vena caval plexi. Mediastinal neuronal projections have been found 
travelling along the superior vena cava and have been associated with arrhythmia 
induction.165 The peri-aortic plexi have been less thoroughly studied but may also 
play some role in arrhythmia formation96, 156, 165. 3) A direct intracardiac pathway 
that has not yet been described may play a role in LAGP-sinus node interactions. 
Finally, each of the above pathways may contribute in some capacity.  
In addition, although we presume that the LAGP is responsible for the 
electrophysiological changes seen with direct epicardial ganglia stimulation, the 
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regional distribution of the response has not yet been characterized. It remains 
unknown whether neuronal activation occurs locally, across the entire atrium, or 
remotely from the stimulation site.   
We hypothesise that the LAGP communicates with the sinus node via a 
central pathway along the vagus nerves and that repolarization changes occur in both 
the right and left atrium with LAGP stimulation.  
1.8 Objectives 
The objective of this work was to delineate the mechanism of the bradycardia 
induced by stimulation of the LAGP. To accomplish this, in addition to identifying 
the pathways responsible for the bradycardic response, we aimed to map the pattern 
of atrial repolarization changes following LAGP stimulation.  
Chapter 2.   Methods 
Twenty-two adult mongrel dogs of either sex, weighing 25-35kg, were 
studied during this experimental protocol. LAGP stimulation was performed at 
baseline and then following each ablation sequence.  
The pathways responsible for the bradycardic response were identified 
through sequential ablation of known autonomic pathways, including vagus nerve 
sectioning, radiofrequency ablation of periaortic and vena cava ganglionated plexi, 
and ablation of the RAGP, which is responsible for most autonomic input into the 
sinus node. Both antegrade and retrograde ablation sequences were performed (see 
below for details). Epicardial isointegral mapping was performed to accomplish the 
further goal of characterizing atrial repolarization changes following LAGP 
stimulation. 
2.1 Ethics 
Experiments were performed in accordance with guidelines set out by the 
Canadian Council of Animal Care166 and approval was obtained from the animal 
research ethics committee of the Sacré-Coeur Hospital Research Center.  
2.2 Experimental protocol 
2.2.1 Anaesthesia 
Anaesthetic induction was performed using intravenous sodium thiopental 
(25 mg/kg) followed by hourly boluses of alpha-chloralose (25mg/kg) intravenously. 
Alpha chloralose was chosen because it is thought to have a limited effect on 
neuronal activity. Each bolus was administered over a period of 5 minutes to 
minimize hemodynamic disturbances. Depth of anaesthesia was evaluated 
continuously by monitoring of jaw tension and by variations in heart rate and blood 
pressure. Mechanical ventilation was maintained with a Harvard Apparatus (Millis, 
MA). Blood oxygen saturation was monitored continuously with lingual pulse-
oxymetry (VetOx G2 Digital, Dolphin medical, Hawthorne, CA). Oxygen flow was 
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adjusted to maintain a partial oxygen saturation (SpO2) of 95% or greater. Body 
temperature was maintained using a heated mat and infrared lamp. The left femoral 
artery and vein were cannulated to facilitate invasive blood pressure monitoring and 
fluid administration. 
2.2.2 Surgery 
Bilateral anterior thoracotomy was performed with the aid of electrocautery 
to ensure adequate hemostasis and both internal mammary arteries and veins were 
ligated with braided silk sutures. The animal is paralyzed (rocuronium 0.5mg/kg) 
during this time to facilitate the initial dissection. A pericardial cradle is created by a 
vertical midline pericardial incision and fixation to the lateral chest walls. This 
ensures exposure of the ascending aorta, superior vena cava, right and left atrial 
ganglionated plexi, and the entire heart. The vagus nerves are exposed in the cervical 
region and encircled with umbilical tape to aid in instrumentation. Epicardial 
electrodes were placed on the atrial and ventricular surfaces for monitoring and 
pacing, respectively. In order to facilitate data analysis, atrial electrograms were 
isolated by atrioventricular (AV) nodal blockade with formaldehyde injection (37%, 
0.1-0.2ml) into the AV node. Right ventricular pacing (60bpm) was instituted to 
maintain adequate cardiac output between periods of nerve stimulation.  
2.2.3 Neuronal stimulation 
Stimulation of both vagus nerves, the RAGP, and the LAGP was performed 
at baseline and following each ablation sequence.  
Vagus nerve stimulation 
Two unipolar electrodes are installed on the vagus nerves bilaterally. These 
electrodes consist of two metallic wires (Medwire, Mount Vernon, NY), individually 
mounted on 25 gauge needles and inserted 1cm longitudinally into the vagus nerve. 
Electrical stimulus is transmitted via a programmable stimulator (Bloom Associates, 
Philadelphia, PA). A supramaximal stimulation (15 Hz, 1mA, 1ms) is transmitted to 
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the vagus nerves. Electrical current is derived from batteries and controlled by a 
grass SD9 stimulator. Amplitude is adjusted according to cardiac response.  
Ganglionated plexus stimulation 
Stimulation of the RAGP and LAGP was accomplished by application of 
bipolar electrodes (1.5 mm apart) mounted on a probe connected to a battery-driven 
current source controlled by a programmable stimulator (Bloom Associates, 
Philadelphia, Pa). Stimulation was triggered by a reference signal derived from a 
pair of electrodes sutured onto atrial muscle. A train of 5 electrical stimuli (15Hz, 3-
4mA, 1ms) was delivered to the RAGP and the superior, intermediate, and inferior 
left atrial epicardial ganglionated plexi during the atrial refractory period to avoid 
muscle activation. Stimulation was continued until the bradycardic response 
stabilized or it became clear that no bradycardia would occur at a given site. This 
was performed at multiple sites in each left atrial ganglionated plexus region to 
ensure identification of a bradycardic response if the potential existed. If multiple 
sites in the LAGP responded to stimulation (e.g. cranial and caudal plexi), the area 
with the greatest bradycardic change was used for data analysis. 
2.2.4 Neuronal ablation 
Vagal decentralisation 
As the only direct pathway of communication between the ICNS and the 
central nervous system is the vagus nerve, this was chosen at the target for 
decentralisation. Decentralisation was accomplished by vagus nerve sectioning at the 
mid cervical level.  
Ganglionated plexus ablation 
Ablation of the periaortic, SVC plexi, and the RAGP was accomplished with 
a monopolar radiofrequency probe (Medtronic, Minneapolis, MN). The probe was 
set at 25 Watts, with ablation times of 20 seconds per centimetre to ensure 
transmurality. Periaortic ablation consisted of RF application to all epiaortic fat 
surrounding the aortic root. SVC plexus ablation consisted of circumferential RF 
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application to the SVC and the fatty tissue located medially. The RAGP was ablated 
by RF application to the entire collection of adipose tissue located on the right 
atrium just below the SVC-right atrial junction.  
2.3 Electrocardiographic evaluation 
2.3.1 Activation Mapping 
Silicone plaques carrying 191 unipolar recording contacts (4.6- to 5.9-mm 
spacing) were positioned on right and left atrial surfaces in order to capture atrial 
unipolar electrograms.141, 142 These plaques covered the right atrial free wall, 
inferoposterior left atrium and coronary sinus, the posterior left atrium between the 
pulmonary veins, the left atrial free wall, and the interatrial band (Figure	   10). A 
surface electrogram is recorded at each electrode and the signal is transmitted to a 
multichannel recorder (EDI 12/256, Institut de génie biomédical, École 
Polytechnique de Montréal) controlled by custom-made software (Cardiomap III: 
www.crhsc.mtl.rtss.qc.ca/ cardiomap) using a PC computer. Unipolar electrograms 
(measured with reference to 4 limb leads) were amplified (0.05 to 450 Hz) and 
converted to digital format at 1000 samples/s/channel. Activation times were 
identified at maximum negative potential displacement (dV/dtmax). Colour-coded 
isochronal maps (10-ms intervals) were computed automatically by linear 
interpolation. The site corresponding to the earliest activation is determined at 
baseline in sinus rhythm and with the earliest bradycardic beat during neuronal 
stimulation (Figure	  11).  
2.3.2 Repolarization mapping 
The spatial distribution of neural effects on repolarization was assessed using 
isointegral mapping. The Cardiomap program was used to adjust the baseline joining 
isoelectric segments between the end of repolarisation of one atrial activation 
complex and the beginning of the following activation. The net area (integral) 
subtended by each unipolar electrogram is calculated by the modified Simpson 
method.167 This is measured at each recording site during baseline sinus beats and 
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sinus beats during LAGP stimulation. By algebraic subtraction of the integral value 
for the basal beat from the integral value measured during nerve stimulation, area 
difference maps are plotted indicating the atrial regions that were affected by nerve 
stimulation.141, 142(Figure 12) Regional atrial repolarization maps can be presented as 
either selected examples in individual experiments or cumulative maps summarizing 
data from several animals. Cumulative incidence maps indicate, for each recording 
site, the proportion of animals in which repolarization changes were induced beyond 
a threshold of 30mV·ms (corresponding to the maximal variation among unipolar 
recordings of 2 standard deviations of changes in repeated measurements under 
baseline conditions). A typical example of right vagus nerve stimulation is shown in 
Figure 13 with the blue areas representing positive isointegral changes, which are 
repolarisation changes seen on atrial electrograms.  
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Figure 10. Schematic representation of atrial epicardial mapping electrode 
plaques. The	  left	  atrial	  (LA)	  and	  right	  atrial	  (RA)	  surfaces	  are	  shown	  unfolded	  and	  viewed	  from	  a	  posterior	  projection.	  Epicardial	  plaque	  electrodes	  were	  positioned	  over	  1)	  the	  RA	  free	  wall	  (yellow)	  and	  appendage	  (green),	  (2)	  the	  lateral	  LA	  wall	  and	  posterior	  LA	  wall	  between	  the	  pulmonary	  veins	  (PV)	  	  (orange),	  (3)	  the	  LA	  appendage	  (LAA)	  (pink),	  and	  (4)	  Bachmann’s	  bundle	  (blue).	  SVC	  =	  Superior	  vena	  cava,	  IVC	  =	  Inferior	  vena	  cava,	  CS	  =	  Coronary	  sinus.	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Figure 11. Example of atrial activation map. The	  star	  represents	  the	  site	  of	  earliest	  atrial	  activation.	  The	  colours	  represent	  the	  time	  elapsed	  between	  the	  site	  of	  earliest	  activation	  and	  all	  other	  recording	  sites.	  	  	  
  
Figure 12. Principles of isointegral mapping.141 	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Figure 13. Example of repolarisation map during vagal stimulation.  The	  colours	  represent	  changes	  in	  the	  repolarisation	  period.	  The	  blue	  area	  (delineated	  by	  the	  orange	  line)	  corresponds	  to	  the	  zone	  where	  all	  changes	  were	  significant	  (greater	  than	  50mV·ms)	  when	  comparing	  stimulation	  to	  the	  Baseline	  state.	  	  
 
 
Figure 14. Experimental protocol. A	  –	  Antegrade	  ablation	  sequence,	  B	  –	  Retrograde	  ablation	  sequence.	  	  *	  Denotes	  LAGP	  stimulation	  with	  activation	  and	  repolarisation	  map	  acquisition.	  (Modified	  from	  Netter,	  Atlas	  of	  Human	  anatomy,	  2nd	  edition,	  1997)	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Figure 15. Experimental protocol timeline.  Sequence	  of	  stimulation	  and	  ablation	  for	  the	  antegrade	  group.	  The	  sequence	  was	  reversed	  in	  the	  retrograde	  group.	  	  
2.4 Experimental protocol 
The experimental protocol is depicted in Figure 14 and Figure 15. Following 
surgical preparation, as described above, baseline activation maps are recorded. This 
is followed by sequential stimulation of the right vagus nerve, the left vagus nerve, 
the RAGP, and the cranial, intermediate, and caudal LAGP. The atrial response to 
each stimulation is recorded with the help of the 191 electrodes on the epicardial 
surface. This permits the establishment of baseline values of the bradycardic 
response to vagal and plexus stimulation. Stimulation of these structures is carried 
out following each ablative intervention, as shown in Figure 14. The protocol 
included both an antegrade and a retrograde ablation sequence, in order to control 
for time related variations in neuronal response. In the antegrade group (n=17), the 
ablation sequence was: 1) Decentralisation, by vagal sectioning, 2) Radiofrequency 
ablation of the peri-aortic and SVC plexi, 3) Radiofrequency ablation of the RAGP. 
At baseline and following ablation of each pathway, stimulation of both vagus 
nerves, the RAGP, and the cranial, intermediate, and caudal LAGP is performed 
sequentially. If there was no inducible bradycardic response to LAGP stimulation 
either at baseline or after a given ablation set, the experiment was continued 
throughout the subsequent ablation step. This was done to maximize the possibility 
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of eliciting a bradycardic response from the LAGP if at all possible. In the 
retrograde group (n=5), ablation was performed in the following order: 1) RAGP 
radiofrequency ablation, 2) peri-aortic SVC radiofrequency ablation, 3) 
decentralisation by bilateral vagus nerve sectioning. Vagus nerve and ganglionated 
plexus ablation was performed as described above for the antegrade group.   
In order to limit confounding factors related to hemodynamic changes during 
induced bradycardia, ventricular pacing wires were placed on the right ventricle at 
initial preparation. The ventricles were paced at 60bpm throughout the experiment, 
maintaining adequate arterial pressure and cardiac output. Ventricular pacing was 
only briefly interrupted during neuronal stimulation to allow data acquisition without 
artefact from ventricular activation.  
2.5 Data analysis 
Parameters studied were atrial bradycardia, spatial distribution of effect of 
LAGP stimulation on atrial tissue, and the effect of LAGP stimulation on 
bradycardia and atrial repolarisation with each ablation sequence.  
2.5.1 Bradycardia 
Subtracting the time interval between each atrial beat at the sinus node allows 
one to determine the sinus rate at baseline and during stimulation. The difference 
between the atrial rate at baseline and during stimulation defines the bradycardic 
effect of that stimulation. This difference was calculated at baseline and then 
compared to subsequent stimulations following each step in the ablative protocol.  
2.5.2 Isointegral distribution mapping following neuronal 
stimulation The	   incidence	   of	   regional	   neuronal	   repolarisation	   effects	  was	   assessed	  by	   tallying,	   for	   each	   recording	   site,	   the	   number	   of	   preparations	   that	  represented	  changes	  on	  the	  integral	  electrogram	  greater	  than	  a	  threshold	  value	  of	  +30	  mV·ms	  or	  the	  equivalent	  of	  2	  standard	  deviations	  of	  the	  value	  obtained	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by	  subtracting	  two	  sets	  of	  measurements	  recorded	  during	  basal	  conditions.141	  The	  results	  are	  represented	  graphically	  on	  an	  atrial	  map	  depicting	  the	  position	  of	   the	   191	   electrodes.	   Cumulative	   incidence	   maps	   were	   generated,	   with	   the	  number	   of	   preparations	   that	   showed	   significant	   repolarisation	   changes	  (REPOL∆)	   at	   each	   site	   indicated	   by	   the	   designated	   colour	   code.	   The	   atrial	  surface	   (mm2)	   showing	   REPOL∆ was	   calculated	   based	   on	   the	   number	   of	  electrodes	   recording	   changes	   above	   the	   pre-­‐established	   threshold.	   This	  calculation	   takes	   into	   account	   the	   triangular	   area	   formed	   by	   three	   recording	  electrodes,	   which	   varies	   from	   0.22cm2	   to	   0.35cm2.	   To	   facilitate	   data	   analysis	  and	   interpretation,	   the	   electrode	   plaques	  were	   divided	   into	   the	   following	   six	  atrial	  regions	  (see	  Figure	  16);	  1)	  right	  atrial	  free	  wall,	  2)	  right	  atrial	  appendage,	  3)	   Bachmann’s	   bundle,	   4)	   left	   atrial	   appendage,	   5)	   left	   atrial	   free	   wall,	   6)	  posterior	  left	  atrial	  wall	  (between	  the	  pulmonary	  veins).	  	  
	  
Figure 16. Designated atrial regions based on electrode plaque location. 1)	  Right	  atrial	  free	  wall,	  2)	  right	  atrial	  appendage,	  3)	  Bachmann’s	  bundle,	  4)	  left	  atrial	   appendage,	  5)	   left	   atrial	   free	  wall,	   6)	  posterior	   left	   atrial	  wall	   (between	  the	   pulmonary	   veins).	   Coloured	   numbers	   on	   edge	   of	   map	   represent	   area	  enclosed	  by	  a	  triangle	  between	  electrodes	  on	  a	  given	  plaque.	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2.5.3 Effect of LAGP stimulation atrial repolarisation with 
sequential ablation 
The changing effects of LAGP stimulation on atrial bradycardic response and 
atrial repolarisation were assessed. For each preparation, the bradycardic response at 
baseline was compared to the response following each subsequent ablation set. 
Surface area of atrial repolarisation change were analysed in the same way. The 
results for each preparation were analysed together to generate cumulative incidence 
maps.  
2.5.4 Statistics 
The data was analysed using the statistics software SPSS version 16. The 
paired Student t test was used to compare continuous variables, i.e. bradycardic 
response to stimulation and the distribution of neuronal influence on atrial 
repolarisation. Statistical significance was set at 0.05. The data is presented as the 
mean ± standard deviation when appropriate. 
Chapter 3.   Results 
3.1 Bradycardia 
3.1.1 LAGP stimulation, antegrade group 
Bradycardia was induced in 17 of 22 animals, equivalent to 77%. This 
included 12 of 17 dogs in the antegrade group and 5 of 5 in the retrograde group. 
This is represented graphically in Figure 17. A persistent bradycardic response 
following RAGP ablation was present in 5 of 12 dogs when both groups are 
combined. Figure 18 shows the average cycle length change with LAGP stimulation 
in the antegrade group at baseline and following each step in the ablation protocol. 
In this figure, all preparations were included for analysis, regardless of bradycardic 
response to stimulation following ablation. In basal conditions, the cycle length (CL) 
increased by 38±15 ms (p<0.002). This corresponds to a slowing of the sinus rate 
from 149±34bpm to 136±28bpm. Figure 19 compares the average change in cycle 
length from baseline and following ablation at each step of the antegrade protocol. 
Values were only included for analysis if the bradycardia was induced at baseline 
and following a given ablation. There was no significant change in cycle length 
following decentralization by vagus nerve sectioning. Following periaortic SVC 
ablation, cycle length change decreased significantly, from 44.7±11.6 to 26.1±14.3 
ms. There was no significant difference in cycle length change in the two animals 
that maintained a bradycardic response with RAGP stimulation.  
In the retrograde ablation group, there was a significant lengthening of cycle 
length with LAGP stimulation at baseline in all canines, from 377.0±80.0ms to 
427.2±75.7ms (∆ = 50.2, p<0.01) (Figure 20). This cycle length prolongation 
persisted in 3 of the 5 dogs following RAGP ablation, with an average cycle length 
increase of 31.7±25.7ms. There was no cycle length change with LAGP stimulation 
upon completion of Ao/SVC ablation. 
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Figure 17. Number of dogs presenting bradycardic response to LAGP 
stimulation at baseline and following sequential ablations. A	  -­‐	  Antegrade	  group,	  B	  –	  Retrograde	  group.	  AO/SVC	  =	  periaortic	  and	  superior	  vena	  cava	  plexi.	  RAGP	  =	  Right	  atrial	  ganglionated	  plexus.	  	  	  
 
Figure 18. Average change in cycle length with LAGP stimulation following 
each step of the ablative protocol. All	  animals	  demonstrating	  bradycardia	  at	  baseline	  are	  represented.	  The	  thick	  yellow	  line	  shows	  the	  mean	  cycle	  length	  change	  decrease	  throughout	  the	  experimental	  protocol.	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Figure 19. Average cycle length change per ablation sequence in the antegrade 
group. Only	  preparations	  showing	  response	  at	  each	  level	  are	  included	  for	  analysis.	  A	  decline	  in	  cycle	  length	  change	  following	  periaortic/SVC	  ablation	  is	  noted.	  	  
	  
Figure 20. Average cycle length change in retrograde group, control versus 
LAGP stimulation There	  was	  a	  significant	  prolongation	  of	  cycle	  length	  with	  LAGP	  stimulation	  at	  baseline.	  Following	  RAGP	  ablation,	  there	  was	  a	  trend	  toward	  prolonged	  cycle	  that	  did	  not	  reach	  statistical	  significance.	  Following	  Ao/SVC	  ablation,	  there	  was	  no	  change	  in	  cycle	  length.	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3.2 Isointegral distribution mapping 
3.2.1 Antegrade ablation sequence 
Right atrial free wall 
Isointegral mapping was available in the final 19 dogs (14/17 in the 
antegrade group, 5/5 in the retrograde group) because AV nodal blockade was not 
performed in the initial 3 preparations. Upon analysis, 14 of the 19 dogs with 
available repolarisation maps showed isointegral REPOL∆ in the right atrium, this 
includes 14 of the 15 dogs that had a bradycardic response to LAGP stimulation.  
Figure 21 shows isointegral maps of two typical preparations. The upper 
series, d11, shows isointegral REPOL∆ that persist following decentralization and 
Ao/SVC ablation, however, the response was suppressed following RAGP ablation. 
The lower series, d10, clearly demonstrates that REPOL∆ in the right atrium 
persisted throughout the entire ablation protocol, including RAGP ablation. Similar 
to the decreasing bradycardic response, surface activation in the right atrium 
decreased throughout the antegrade ablation sequence. These changes can be seen in 
Figure 22. At baseline, REPOL∆ on the right atrial free wall (RAFW) covered 
365±252mm2. Following decentralisation and Ao/SVC ablation there was a 
decreasing trend to 266±283mm2 and 285±328mm2 respectively. Following RAGP 
ablation there was a statistically significant decrease to 53±106mm2 (p<0.03). 
Cumulative incidence maps, Figure 23, depict the progressive decrease of REPOL∆ 
in the antegrade group throughout the protocol.  
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Figure 21. Examples of isointegral mapping with LAGP stimulation. Isointegral	  changes	  in	  2	  representative	  preparations	  from	  the	  antegrade	  group	  are	  shown.	  At	  baseline,	  the	  positive	  isointegral	  changes	  in	  the	  right	  atrium	  (blue	  area)	  are	  consistent	  with	  the	  concomitant	  bradycardia.	  In	  the	  upper	  panel,	  REPOL∆	  diminish	  progressively	  along	  the	  ablation	  sequence	  until	  disappearing	  after	  RAGP	  ablation.	  The	  lower	  panel	  shows	  a	  persistent	  response	  throughout	  all	  ablation,	  including	  the	  RAGP.	  	  
 
 
Figure 22. Surface area of activation along the right atrial free wall with 
progressive ablation in the antegrade group.  There	  is	  a	  trend	  of	  decreased	  surface	  area	  of	  activation	  following	  decentralisation	  and	  Ao/SVC	  ablation,	  while	  there	  is	  a	  statistical	  significance	  decrease	  following	  RAGP	  ablation.	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Bachmann’s bundle 
There was a significant decrease in surface area of REPOL∆ over the entire 
atria following decentralisation compared to baseline (1706±747mm2 vs. 
1149±684mm2, p<0.04). This change was most pronounced in Bachmann’s bundle 
region. Figure 24 compares the surface area of REPOL∆ in Bachmann’s bundle, 
comparing results for each ablative step to the previous one. Following 
decentralisation, REPOL∆ decreased from 295±213mm2 to 178±171mm2 (p<0.03). 
This area decreased further following Ao/SVC ablation to 93±97mm2 (p<0.05).  	  
	  
Figure 23. Cumulative incidence maps of REPOL∆ with antegrade group. 
Repolarisation maps of 9 dogs represented. A progressive decline in surface area of 
atrial activation is observed, particularly in the right atrium. In map B, a significant 
suppression of REPOL∆ in Bachmann’s bundle (shaded area) is noted following 
decentralization.  
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Figure 24. Isointegral changes in Bachmann’s bundle throughout ablation 
sequence.  1	  =	  significant	  decrease	  from	  Baseline	  (black)	  to	  decentralisation	  (grey).	  2	  =	  significant	  decrease	  from	  decentralisation	  to	  Ao/SVC	  ablation.	  3	  =	  insignificant	  change	  from	  Ao/SVC	  to	  RAGP	  ablation.	  *	  =	  p<0.05	  	  
3.2.2 Retrograde ablation 
Surface area isointegral changes for the retrograde ablation group are 
presented in Figure 25. In addition to the bradycardic response, all dogs in the 
retrograde protocol demonstrated repolarisation in the right atrium as a response to 
LAGP stimulation at baseline (269±144mm2). Following RAGP ablation, there 
remained important isointegral changes in the right atrium, although the surface area 
of those changes was significantly less than at baseline (269±144mm2 vs. 
124±158mm2, p<0.05). REPOL∆ were almost completely abolished when the LAGP 
was stimulated following Ao/SVC ablation (4±9mm2). 
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Figure 25. Surface area of activation along the right atrial free wall with 
progressive ablation in the retrograde group. Following	  RAGP	  ablation,	  there	  was	  a	  significant	  decrease	  in	  average	  surface	  area	  of	  activation	  with	  LAGP	  stimulation.	  Isointegral	  changes	  were	  almost	  entirely	  abolished	  following	  Ao/SVC	  ablation,	  although	  this	  did	  not	  reach	  statistical	  significance	  when	  compared	  to	  changes	  post	  RAGP	  ablation.	  *	  =	  p<0.05	  when	  compared	  to	  baseline.	  
	  
Chapter 4.   Discussion 
The present study was designed to define the nature of the sinus bradycardia 
induced by LAGP stimulation in a canine model. The LAGP can be readily 
identified by the bradycardic response to stimulation in the majority of cases, with 
the RAGP being the primary, but not the exclusive, gateway to the sinus node. By 
progressively eliminating autonomic input into the heart, the pathways of this 
response were shown to be variable and overlapping. Stimulation of the LAGP has 
significant neural effects on the right atrium, while it is clear that they are not 
mediated primarily by a central reflex loop, rather by local pericardiac and 
intracardiac nerve fibres. Finally, neural effects in non-chronotropic regions, such as 
Bachmann’s bundle, may be mediated by central reflex pathways between the LAGP 
and atrial tissues.  
4.1 Bradycardia 
A bradycardic response to LAGP stimulation was elicited in 17 of 22 dogs 
(77%), demonstrating that the LAGP can indeed be identified by the bradycardic 
response to electrical stimulation in the intraoperative setting. Butler et al first 
suggested the chronotropic properties of the LAGP in 1990 when they were able to 
elicit a bradycardic response in a significant number of canines with electrical 
stimulation.168 Others authors have since duplicated these results but the 
phenomenon has not been studied systematically and the mechanism of this 
bradycardia has not been hypothesized previously.150 Lu et al have gone the farthest 
in studying the pathway of the bradycardic response to LAGP stimulation, 
suggesting that the RAGP is the primary relay station to the sinus node, however 
bradycardic response to stimulation and AV nodal block were the only parameters 
studied.169 The sequential ablation protocol in this study provides new information 
on the subject. Decentralisation by vagus nerve sectioning suppressed the 
bradycardic response in only one preparation and did not affect the degree of 
bradycardia in the remaining 11 dogs. Bulter et al had similar findings in a study of 
8 canines, only two of which were affected by decentralisation.168 This would 
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suggest that, with regard to the bradycardic properties of the LAGP, the vagus nerve, 
and as a consequence the central nervous system, play only a minor role. Thus it can 
be concluded that LAGP epicardial neurons are not uniquely afferent neurons with 
projections to the central nervous system, rather efferent neurons with pericardiac or 
intracardiac projections that can affect sinus node function. As will be discussed 
later, the central reflex arc may be implicated in nonchronotropic LAGP properties.  
 Following periaortic and SVC plexus ablation, the bradycardic response to 
stimulation was suppressed in 36% (4/11) of the remaining preparations in the 
antegrade group and 100% in the retrograde group (3/3) (Figure 17). In those 
preparations with a persistent bradycardic response, the average cycle change was 
decreased as compared to baseline. These findings are suggestive of two novel 
characteristics of the LAGP. 1) The periaortic/SVC plexi appear to be an important 
pathway in the transmission of neuronal signals from the LAGP to the sinus node, 
likely via the RAGP intermediary. 2) LAGP fibres likely travel along multiple 
pathways in a given heart. This is evidenced by the stepwise decrease in magnitude 
of bradycardia following periaortic/SVC ablation, suggesting truncated but not 
abolished LAGP input into the sinus node. While the periaortic/SVC plexi have been 
implicated as a significant autonomic neuronal pathway by several authors, this 
represents the first description of this pathway as it relates to the LAGP.170-173 
It has been well documented that the RAGP is the chief input of the ANS and 
ICNS into the sinus node117, 174-176. More recently, several authors have suggested 
that the RAGP is the primary but likely not the only input sinus node.115, 142, 177 The 
results of this study mirror those reports, clearly showing that the RAGP is not the 
only pathway by which the ICNS can influence the sinus rate. Furthermore, it has 
not been demonstrated previously that the LAGP has direct communications with 
the sinus node, independent of the RAGP. In the antegrade group, RAGP ablation 
suppressed the bradycardic response in five of the seven dogs that had maintained a 
vagal response following periAo/SVC ablation, while bradycardia persisted in two 
dogs even after RAGP ablation. The results of the retrograde group confirmed these 
findings, with three of five dogs maintaining a bradycardic response even after 
RAGP ablation. Figure 26 summarizes the multiple LAGP pathways that are 
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responsible for the bradycardic response to stimulation. This new information lends 
itself to the idea that the LAGP contains primarily afferent neurons with local 
pathways that can affect cardiac performance on a beat-to-beat basis without passing 
through the central nervous system.  
 
Figure 26. Summary of LAGP pathways responsible for sinus bradycardia. Autonomic	  bodies	  include	  the	  central	  nervous	  system	  (CNS),	  periaortic	  and	  superior	  vena	  cava	  plexus	  (Ao/SVC	  plexus),	  right	  atrial	  ganglionated	  plexus	  (RAGP),	  and	  the	  sinoatrial	  node	  (SA	  node).	  Solid	  and	  dotted	  lines	  represent	  primary	  and	  secondary	  pathways,	  respectively.	  
4.2 Right atrial repolarisation changes 
In classical studies documenting the effects of ganglionated plexus 
stimulation, only chronotropic and dromotropic parameters were used as markers of 
neural effects. Such limited endpoints risk missing effects of neural projections 
remote from the SA and AV nodes. By instrumentation with epicardial mapping 
electrodes and measurement of REPOL∆, Pagé et al have been able to identify 
neural effects in many more atrial sites than identified previously.141, 142. It has been 
shown that positive integral deflections correspond to significant changes in action 
potential duration and allows us to identify areas affected by nerve stimulation.178 
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 This study is the first to focus on the LAGP while evaluating isointegral 
REPOL∆ in addition to the classical chronotropic response. The results clearly 
demonstrate diffuse REPOL∆ across both atria (Figure 23), although not of the same 
magnitude as previously reported with vagal stimulation.141 Importantly, there are 
significant REPOL∆ seen in the right atrium, corresponding to the concomitant 
bradycardia discussed above. In the antegrade group there was a trend toward 
decreasing surface area of REPOL∆ throughout the ablative protocol, with a 
significant decrease following RAGP ablation (Figure 22). In the retrograde group, 
surface area of REPOL∆ decreased significantly following RAGP and Ao/SVC 
plexus ablation (Figure 25). The implications of these finding are two-fold. 1) This 
confirms that the bradycardic response witnessed with LAGP stimulation is indeed 
the result of neural changes in atrial tissue, providing the physioanatomic basis for 
the “vagal” response when electrical stimulation is carried out both experimentally 
and clinically.150, 152, 155, 179, 180 2) As with the bradycardic response, the stepwise 
decrease in surface area of REPOL∆ reveals the complex nature of LAGP-atrial 
interactions. Although the RAGP is an important mediator of LAGP effects on the 
right atrium, there are other pathways, both pericardiac and intracardiac, through 
which the LAGP can modulate cardiac physiology. 
 In one preparation there was no bradycardic response recorded with LAGP 
stimulation, however, there were significant repolarisation changes seen upon 
analysis of epicardial electrode maps. The neurophysiologic basis of this anomaly 
can only be hypothesized at this point. It is possible that this phenomenon was 
present in each of the five preparations that did not produce a bradycardic response 
but because of the experimental design we were unable to isolate the repolarisation 
changes. The atrial electrograms are recorded in real time during the experimental 
protocol, however, due to time constraints while working with a live animal, the 
isointegral maps are not analysed until a later time. As a consequence, in the absence 
of bradycardia the choice of electrograms for analysis is somewhat arbitrary and can 
possibly miss an LAGP activation that may have occurred during an earlier or later 
stimulation. This example brings to light our limited comprehension of the complex 
functions of the ICNS. Each ganglionated plexus may serve a multitude of purposes 
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related to chronotropy, dromotropy, inotropy, or any number of other cardiac 
neurophysiologic regulatory roles. It is important to keep this in mind when 
considering targeted ablation of the ICNS in a clinical therapeutic setting. This 
concept will be elaborated upon in a subsequent section.  
4.3 Bachmann’s bundle 
Since it was first identified in 1916, Bachmann’s bundle has become known 
as the primary interatrial conduction pathway.77, 81, 181-183 More recently, it has been 
experimentally linked to the initiation and propagation of atrial tachyarrhythmias.140, 
182 In the present study, LAGP stimulation caused significant neurally mediated 
repolarization changes in Bachmann’s bundle, as well as in other atrial regions. 
Interestingly, while the changes in Bachmann’s bundle were significantly 
diminished in the antegrade group following decentralization, there was no 
difference in the bradycardic effect of LAGP stimulation. This suggests that 
although primarily local pathways, as detailed above, mediate the bradycardic 
response to LAGP stimulation, the neurally induced repolarization changes in 
Bachmann’s bundle are largely mediated by a central reflex arc via the vagus nerves. 
Previous studies detailing atrial repolarization changes in Bachmann’s bundle have 
found significant neurally induced changes associated with stimulation of a variety 
of mediastinal nerves.140, 141 Pagé et al found repolarization changes in the area of 
Bachmann’s bundle with stimulation of the right vagosympathetic complex and the 
superior vena cava.141 These changes were associated with early bradycardic beats 
preceding the onset of atrial tachyarrhythmia. These findings expose the significant 
neural input from central nerves into Bachmann’s bundle. Our results support the 
notion of considerable central innervation of this area, however, they also once again 
allude to our limited understanding of the intrinsic cardiac nervous system as a 
whole. While LAGP stimulation resulted in significant neural repolarization changes 
that were modified by vagus nerve sectioning, we do not know how these changes 
affect the autonomic nervous system or the heart on which they occur. The 
innervation of Bachmann’s bundle highlights the impressive interconnectivity and 
redundancy of the ICNS. With this in mind, it is difficult to imagine how selective 
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neuroablation, through localized ganglionated plexus ablation, can have a clinically 
relevant effect on arrhythmia formation of preservation.  
4.4 Intrinsic cardiac nervous system remodelling  
The experiments described in this thesis were performed on healthy canines 
with normal atrial tissue. In the presence of disease, such as ischemia, heart failure 
or arrhythmia, the ICNS can undergo significant remodelling, either physiological or 
anatomical, that may alter its response to otherwise benign physiologic stimuli. This 
phenomenon is well described by Armour and is supported by several experimental 
studies.105, 184-188 It has also been demonstrated that therapeutic interventions, such as 
spinal cord stimulation and transmyocardial laser revascularization, can have lasting 
effects on the ICNS.187, 188 The current study adds to our knowledge of the 
neuroanatomy of the ICNS, providing another element to our global understanding 
of this complex system. Further work is needed in order to integrate this information 
into a model of pathologic atrial remodelling. Remodelling can contribute to or 
exacerbate cardiac disease by several mechanisms. and thus react differently to 
stimuli. out a history of arrhythmia and therefore a  atrial fibrillation remodelling   
4.5 LAGP ablation in treatment of atrial fibrillation 
The results of the current study uncover important information regarding the 
functional anatomy of the LAGP. Although this work cannot be extrapolated to a 
conclusion regarding the arrhythmogenic potential of this group of neurons, 
understanding the basic workings of the LAGP is particularly important in light of 
the increasing role it plays in the interventional treatment of AF. 
 Several authors have explored the arrhythmogenic potential of the LAGP 
both experimentally and clinically. Despite the growing number of clinical reports 
describing LAGP ablation in the treatment of AF, there is surprisingly little 
experimental evidence supporting this practice. Lu et al investigated the effects of 
LAGP ablation on AF threshold and found that the threshold for AF induction was 
higher following ablation of a variety of ganglionated plexi, including the LAGP.189 
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The methodology of this study may be challenged because a bipolar ablation probe 
was used to carry out the ablation, which essentially studies the effect of transmural 
ablation lines in the area of the pulmonary veins rather than isolated ablation of 
ganglionated plexi. Although this study may not prove the arrhythmogenic potential 
of the LAGP, it is in line with the rest of the AF literature advocating pulmonary 
vein ablation for the treatment of AF. Lemola et al recently published more 
convincing results with regard to the role of the LAGP in AF formation.190 While 
studying thirty mongrel dogs, they showed that intact pulmonary vein-left atrial 
connections were not necessary to maintain vagal AF, yet epicardial ablation of 
ganglionated plexi suppressed vagal responses. Despite their findings, the authors do 
caution that selective ablation alone is likely not as effective as a combined approach 
with pulmonary vein circumferential ablation and vagal denervation.  
Clinical studies have reported generally favourable results with ganglionated 
plexus ablation but also give reason to proceed with caution. Pokushalov et al 
reported two-year follow-up of ganglionated plexus ablation with a success rate of 
38% in patients with persistent AF and slightly better results when combined with 
pulmonary vein isolation.191 These results suggest some effect of ganglionated 
plexus ablation but are certainly disappointing as a therapeutic intervention. The 
same group reported better results in patients with paroxysmal AF, with 71% in 
sinus rhythm at twelve months. Interestingly, they did not attempt to identify ganglia 
through the bradycardic response but instead employed an “anatomical” ablation 
approach, applying a radiofrequency probe to the sites where autonomic ganglia 
have been reportedly been located in the literature. As the authors state, the more 
common practice of high frequency stimulation to guide ablation may illicit 
responses in local autonomic nerves rather than the autonomic ganglia themselves 
and therefore may not be a suitable marker on which to base ablative interventions.  
Other authors have reported pulmonary vein isolation with a minimally 
invasive approach with the addition of ganglionated plexus localisation by high 
frequency stimulation and subsequent ablation. Success rates vary from 77-87% for 
paroxysmal AF and are significantly lower for persistent AF.179, 192, 193 A difficulty 
with each of these studies is that there is no evidence that selective ganglionated 
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plexus ablation had any bearing on the freedom from AF, in other words, pulmonary 
vein isolation alone may have yielded the same outcome. In fact, there is some 
evidence that selective denervation following identification with high frequency 
stimulation may be deleterious by causing heterogeneity in the atrial tissue, an idea 
that has been echoed by several authors.180, 194, 195 The effect of the complete Maze 
procedure on the ICNS is difficult to qualify and has not been systematically studied.  
The extensive nature of ablation lines likely effect some degree of ICNS 
remodelling, but further work must be done to better understand these interactions. 
There have been a limited number of clinical studies suggesting that patients can 
benefit from the addition of ganglionated plexus ablation to the conventional Maze 
procedure.196 Although this data is far from conclusive, it would suggest that the 
Maze procedure alone does not adequately address arrhythmias originating in the 
ICNS. 
The present study demonstrates that the LAGP likely does contain efferent 
neurons that modulate cardiac neurophysiology locally and therefore could 
theoretically be involved in arrhythmia formation. However, the complex pathways 
described above open a small window into the previously demonstrated complexity 
of the ICNS. This should raise a concern that selective neuroablative interventions 
may not produce the desired effect if based on an oversimplification of this elaborate 
and somewhat unpredictable network of neurons.112, 177 Several avenues of study 
must be completed before determining the role that these ganglionated plexi play in 
arrhythmia formation. These must include chronic animal models permitting the 
evaluation of atrial remodelling with and without ganglionated plexus ablation. The 
results of an ongoing study in our laboratory may shed some light on this subject. In 
a chronic dog model with rapid atrial pacing, the effect of bilateral anatomical 
ganglionated plexus ablation on atrial refractoriness and AF induction is being 
evaluated. The results, whether positive or negative, should enhance our knowledge 
regarding this important topic. 
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4.6 Limitations When	   using	   animal	   models	   to	   simulate	   human	   anatomy	   and	   pathology,	   one	  should	   always	   be	   cognizant	   of	   important	   interspecies	   differences.	   Regarding	  the	   ICNS,	   anatomic	   studies	   have	   demonstrated	   adequate	   correlation	   between	  canines	  and	  humans,	  and	  pathophysiologic	  reactions	  to	  various	  stimuli	  tend	  to	  correspond	  adequately.96,	  114	  One	  concern	  in	  this	  particular	  model	  was	  time	  as	  a	  confounding	   variable	   in	   the	   decreasing	   bradycardic	   response.	   Two	   sham	  procedures	   were	   performed	   to	   assess	   whether	   the	   decreasing	   bradycardic	  response	  was	   simply	  due	   to	   time	   related	   fatigue	  of	   the	  neuronal	   response.	   In	  these	   procedures,	   the	   bradycardic	   response	   to	   stimulation	   persisted	  throughout,	   implying	   that	   the	   diminishing	   or	   extinguished	   bradycardic	  response	   in	   the	   study	   group	   was	   in	   fact	   a	   result	   of	   the	   sequential	   ablation	  sequences.	  Additionally,	  no	  histologic	  or	  pathologic	  analysis	  of	  atrial	  tissue	  was	  completed	  to	  verify	  the	  presence	  of	  neurons	  in	  the	  stimulated	  areas.	  Although	  this	   may	   have	   been	   an	   interesting	   adjunct	   to	   the	   experiments,	   it	   was	  unnecessary	   because	   stimulation	   was	   performed	   during	   the	   absolute	   atrial	  refractory	   period,	   thus	   ensuring	   neuronal	   and	   not	   myocardial	   activation.	  Transmurality	  of	   radiofrequency	  ablation	  was	  not	   verified,	   however,	   this	  was	  not	   essential	   since	   ganglionated	   plexi	   are	   known	   to	   lie	   primarily	   on	   the	  epicardial	   surface	   of	   the	   heart.	   Finally,	  while	   the	   LAGP	   is	   likely	   present	   in	   all	  canines,	   we	   were	   unable	   to	   demonstrate	   neurally	   mediated	   repolarization	  changes	  in	  33%.	  Even	  though	  it	  is	  possible	  that	  repolarization	  changes	  occur	  in	  the	   absence	   of	   chronotropic	   changes,	  we	  were	   dependent	   on	   the	   bradycardic	  response	  to	  stimulation	  as	  a	  sign	  of	  LAGP	  activation.	  While	  this	   is	  an	  inherent	  limitation	  of	   the	  model,	   it	   is	   representative	  of	  what	   can	  occur	   clinically	  when	  intraoperative	   ganglionated	   plexus	   stimulation	   is	   performed.	   Despite	   these	  pertinent	   limitations,	   the	   results	   described	   above	   remain	   applicable	   and	  persuasive.	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Chapter 5.   Conclusion This	   study	   attempted	   to	   define	   the	   nature	   of	   the	   sinus	   bradycardia	  induced	   by	   LAGP	   stimulation	   in	   a	   canine	   model.	   We	   have	   shown	   that	   LAGP	  stimulation	   has	   significant	   effects	   on	   the	   right	   atrium.	   By	   progressively	  eliminating	   autonomic	   input	   into	   the	   heart	   we	   were	   able	   to	   show	   that	   the	  pathways	   of	   this	   response	   are	   variable	   and	   overlapping.	   It	   is	   clear	   that	   the	  bradycardic	  response	  is	  not	  mediated	  primarily	  by	  a	  central	  reflex	  loop,	  rather	  by	  local	  pericardiac	  and	  intracardiac	  nerve	  fibres.	  The	  periaortic/SVC	  plexi	  are	  important	  in	  relaying	  neuronal	  signals	  from	  the	  LAGP	  to	  right	  sided	  structures,	  and	  there	  may	  even	  be	  a	  direct	   line	  of	  communication	  between	  the	  LAGP	  and	  the	   sinus	   node.	   In	   addition	   to	   confirming	   the	  marked	   neuronal	   effects	   of	   the	  LAGP	  on	  the	  right	  atrium,	  mapping	  atrial	  repolarization	  changes	  highlighted	  the	  complexity	   of	   the	   neuronal	   projections	   by	   unmasking	   the	   suppression	   of	  repolarization	  changes	  in	  Bachmann’s	  bundle	  following	  decentralization.	  	  These	  findings	  suggest	  the	  presence	  of	  both	  afferent	  and	  efferent	  neurons	  in	  the	  LAGP.	  As	   this	   pertains	   to	   the	   current	   trend	   in	   the	   treatment	   of	   AF,	   notably	   the	  adjunctive	   targeted	   ganglionated	   plexus	   ablation	   procedures,	   our	   findings	  maintain	  the	  possibility	  that	  ablation	  of	  these	  neurons	  could	  affect	  arrhythmia	  inducibility.	  However,	  although	  we	  have	  been	  able	  to	  elucidate	  the	  pathways	  of	  these	   nerve	   fibres,	   their	   function	   and	   role	   in	   atrial	   fibrillation	   remains	   to	   be	  determined.	   Even	   if	   these	   plexi	   prove	   to	   have	   arrhythmogenic	   potential,	   the	  ideal	  ablation	  technique	  is	  yet	  to	  be	  determined.	  Owing	  to	  the	  overlapping	  and	  complex	  nature	  of	  the	  cardiac	  autonomic	  nervous	  system,	  focal	  ablation	  within	  ganglionated	   plexi	   may	   not	   produce	   the	   desired	   effect	   of	   arrhythmia	  termination.	   Rather,	   a	   more	   global	   approach	   to	   cardiac	   denervation	   may	   be	  indicated.  
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